• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    Amendment: SEC Form SCHEDULE 13G/A filed by Zepp Health Corporation

    5/7/25 11:05:28 AM ET
    $ZEPP
    Computer Manufacturing
    Technology
    Get the next $ZEPP alert in real time by email



    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549


    SCHEDULE 13G


    UNDER THE SECURITIES EXCHANGE ACT OF 1934
    (Amendment No. 6)


    ZEPP HEALTH CORP

    (Name of Issuer)


    CLASS A COMMON STOCK

    (Title of Class of Securities)


    98945L204

    (CUSIP Number)


    04/30/2025

    (Date of Event Which Requires Filing of this Statement)


    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
    Checkbox checked   Rule 13d-1(b)
    Checkbox not checked   Rule 13d-1(c)
    Checkbox not checked   Rule 13d-1(d)






    SCHEDULE 13G

    CUSIP No.
    98945L204


    1Names of Reporting Persons

    FIL Limited
    2Check the appropriate box if a member of a Group (see instructions)

    Checkbox not checked  (a)
    Checkbox not checked  (b)
    3Sec Use Only
    4Citizenship or Place of Organization

    BERMUDA
    Number of Shares Beneficially Owned by Each Reporting Person With:
    5Sole Voting Power

    9,898,944.00
    6Shared Voting Power

    0.00
    7Sole Dispositive Power

    11,512,688.00
    8Shared Dispositive Power

    0.00
    9Aggregate Amount Beneficially Owned by Each Reporting Person

    11,512,688.00
    10Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

    Checkbox not checked
    11Percent of class represented by amount in row (9)

    10.2 %
    12Type of Reporting Person (See Instructions)

    FI


    SCHEDULE 13G

    CUSIP No.
    98945L204


    1Names of Reporting Persons

    Pandanus Partners, L.P.
    2Check the appropriate box if a member of a Group (see instructions)

    Checkbox not checked  (a)
    Checkbox not checked  (b)
    3Sec Use Only
    4Citizenship or Place of Organization

    DELAWARE
    Number of Shares Beneficially Owned by Each Reporting Person With:
    5Sole Voting Power

    0.00
    6Shared Voting Power

    0.00
    7Sole Dispositive Power

    11,512,688.00
    8Shared Dispositive Power

    0.00
    9Aggregate Amount Beneficially Owned by Each Reporting Person

    11,512,688.00
    10Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

    Checkbox not checked
    11Percent of class represented by amount in row (9)

    10.2 %
    12Type of Reporting Person (See Instructions)

    PN


    SCHEDULE 13G

    CUSIP No.
    98945L204


    1Names of Reporting Persons

    Pandanus Associates, Inc.
    2Check the appropriate box if a member of a Group (see instructions)

    Checkbox not checked  (a)
    Checkbox not checked  (b)
    3Sec Use Only
    4Citizenship or Place of Organization

    DELAWARE
    Number of Shares Beneficially Owned by Each Reporting Person With:
    5Sole Voting Power

    0.00
    6Shared Voting Power

    0.00
    7Sole Dispositive Power

    11,512,688.00
    8Shared Dispositive Power

    0.00
    9Aggregate Amount Beneficially Owned by Each Reporting Person

    11,512,688.00
    10Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

    Checkbox not checked
    11Percent of class represented by amount in row (9)

    10.2 %
    12Type of Reporting Person (See Instructions)

    CO


    SCHEDULE 13G

    Item 1. 
    (a)Name of issuer:

    ZEPP HEALTH CORP
    (b)Address of issuer's principal executive offices:

    BUILDING B2, ZHONG'AN CHUANGGU,TECHNOLOGY PARK NO.900 WANGJIANG WEST RD,HEFEI,F4,230088
    Item 2. 
    (a)Name of person filing:

    FIL Limited
    (b)Address or principal business office or, if none, residence:

    Pembroke Hall, 42 Crow Lane, Hamilton, Bermuda, HM19
    (c)Citizenship:

    Not applicable
    (d)Title of class of securities:

    CLASS A COMMON STOCK
    (e)CUSIP No.:

    98945L204
    Item 3.If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
    (a)Checkbox not checked   Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
    (b)Checkbox not checked   Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
    (c)Checkbox not checked   Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
    (d)Checkbox not checked   Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
    (e)Checkbox not checked   An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
    (f)Checkbox not checked   An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
    (g)Checkbox not checked   A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
    (h)Checkbox not checked   A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
    (i)Checkbox not checked   A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
    (j)Checkbox checked   A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J),
           please specify the type of institution:
    (k)Checkbox not checked   Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
     
    Please see Exhibit 99.
    Item 4.Ownership
    (a)Amount beneficially owned:

    11512688.00
    (b)Percent of class:

    10.2  %
    (c)Number of shares as to which the person has:
     (i) Sole power to vote or to direct the vote:

    Please see the responses to Items 5 and 6 on the cover page.

     (ii) Shared power to vote or to direct the vote:

    0.00

     (iii) Sole power to dispose or to direct the disposition of:

    11512688.00

     (iv) Shared power to dispose or to direct the disposition of:

    0.00

    Item 5.Ownership of 5 Percent or Less of a Class.
     
    Item 6.Ownership of more than 5 Percent on Behalf of Another Person.
     
    If any other person is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, such securities, a statement to that effect should be included in response to this item and, if such interest relates to more than 5 percent of the class, such person should be identified. A listing of the shareholders of an investment company registered under the Investment Company Act of 1940 or the beneficiaries of employee benefit plan, pension fund or endowment fund is not required.


    One or more other persons are known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the CLASS A COMMON STOCK of ZEPP HEALTH CORP. The interest of Fidelity China Special Situations PLC, in the CLASS A COMMON STOCK of ZEPP HEALTH CORP, amounted to 6581376.00 shares or 5.8% of the total outstanding CLASS A COMMON STOCK at 04/30/2025.
    Item 7.Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
     
    If a parent holding company has filed this schedule, pursuant to Rule 13d-1(b)(ii)(G), so indicate under Item 3(g) and attach an exhibit stating the identity and the Item 3 classification of the relevant subsidiary. If a parent holding company has filed this schedule pursuant to Rule 13d-1(c) or Rule 13d-1(d), attach an exhibit stating the identification of the relevant subsidiary.


    See attached Exhibit 99.
    Item 8.Identification and Classification of Members of the Group.
     
    Not Applicable
    Item 9.Notice of Dissolution of Group.
     
    Not Applicable

    Item 10.Certifications:
     
    By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.

        SIGNATURE 
     
    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

     
    FIL Limited
     
    Signature:Stephanie J. Brown
    Name/Title:Duly authorized under Power of Attorney effective as of December 19, 2022, by and on behalf of FIL Limited and its direct and indirect subsidiaries*
    Date:05/06/2025
     
    Pandanus Partners, L.P.
     
    Signature:Stephanie J. Brown
    Name/Title:Duly authorized under Power of Attorney effective as of December 19, 2022, by Pandanus Associates, Inc. on behalf of Pandanus Partners, L.P.*
    Date:05/06/2025
     
    Pandanus Associates, Inc.
     
    Signature:Stephanie J. Brown
    Name/Title:Duly authorized under Power of Attorney effective as of December 19, 2022, by and on behalf of Pandanus Associates, Inc.*
    Date:05/06/2025

    Comments accompanying signature:  * This power of attorney is incorporated herein by reference to Exhibit 24 to the Schedule 13G filed by FIL Limited on January 31, 2023, accession number: 0000318989-23-000005.
    Exhibit Information

    Please see Exhibit 99 for 13d-1(k) (1) agreement.

    Get the next $ZEPP alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $ZEPP

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $ZEPP
    Financials

    Live finance-specific insights

    See more
    • Zepp Health Corporation to Report First Quarter 2025 Financial Results on May 19, 2025

      Earnings Call Scheduled for 9:00 p.m. ET on May 19, 2025 MILPITAS, Calif., May 7, 2025 /PRNewswire/ -- Zepp Health Corporation ("Zepp Health" or the "Company") (NYSE:ZEPP), a global leader in smart wearables and health technology, today announced that it will report its first quarter 2025 unaudited financial results after the market close on Monday, May 19, 2025. Management will hold a conference call at 9:00 p.m. Eastern Time on Monday, May 19, 2025. Listeners may access the call by dialing: US (Toll Free): +1-888-346-8982 International: +1-412-902-4272 Mainland China (Toll Free): 400-120-1203 Hong Kong (Toll Free): 800-905-945 Hong Kong: +852-3018-4992 Participants should dial in at leas

      5/7/25 8:00:00 AM ET
      $ZEPP
      Computer Manufacturing
      Technology
    • Zepp Health Corporation Reports Fourth Quarter and Full Year 2024 Unaudited Financial Results

      MILPITAS, Calif., March 26, 2025 /PRNewswire/ -- Zepp Health Corporation ("Zepp" or the "Company") (NYSE:ZEPP) today announced its unaudited financial results for the fourth quarter of 2024. Fourth Quarter 2024 Financial and Operating Highlights: Revenue reached US$59.5 million representing a 40.2% of quarter over quarter increase, out of which our Amazfit-branded products grew by 43.4% quarter-over-quarter.Gross margin was 36.8% compared with 34.7% in the same period last year.Adjusted operating loss[1] was US$7.4 million, which was the lowest level in 2024.Full Year 2024 Financial and Operating Highlights: Gross margin was 38.5% compared with 26.2% in the full year of 2023.Adjusted operat

      3/26/25 5:00:00 PM ET
      $ZEPP
      Computer Manufacturing
      Technology
    • Zepp Health Corporation to Report Fourth Quarter and Full Year 2024 Financial Results on March 26, 2025

      Earnings Call Scheduled for 7:00 p.m. ET on March 26, 2025 MILPITAS, Calif., March 18, 2025 /PRNewswire/ -- Zepp Health Corporation ("Zepp Health" or the "Company") (NYSE:ZEPP), a global leader in smart wearables and health technology, today announced that it will report its fourth quarter and full year 2024 unaudited financial results after the market close on Wednesday, March 26, 2025. Management will hold a conference call at 7:00 p.m. Eastern Time on Wednesday, March 26, 2025. Listeners may access the call by dialing: US (Toll Free): +1-888-346-8982 International: +1-412-902-4272 Mainland China (Toll Free): 400-120-1203 Hong Kong (Toll Free): 800-905-945 Hong Kong: +852-3018-4992 Parti

      3/18/25 8:00:00 AM ET
      $ZEPP
      Computer Manufacturing
      Technology

    $ZEPP
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Zepp Health Corporation to Report First Quarter 2025 Financial Results on May 19, 2025

      Earnings Call Scheduled for 9:00 p.m. ET on May 19, 2025 MILPITAS, Calif., May 7, 2025 /PRNewswire/ -- Zepp Health Corporation ("Zepp Health" or the "Company") (NYSE:ZEPP), a global leader in smart wearables and health technology, today announced that it will report its first quarter 2025 unaudited financial results after the market close on Monday, May 19, 2025. Management will hold a conference call at 9:00 p.m. Eastern Time on Monday, May 19, 2025. Listeners may access the call by dialing: US (Toll Free): +1-888-346-8982 International: +1-412-902-4272 Mainland China (Toll Free): 400-120-1203 Hong Kong (Toll Free): 800-905-945 Hong Kong: +852-3018-4992 Participants should dial in at leas

      5/7/25 8:00:00 AM ET
      $ZEPP
      Computer Manufacturing
      Technology
    • Zepp Health Corporation Files 2024 Annual Report on Form 20-F

      MILPITAS, Calif., April 25, 2025 /PRNewswire/ -- Zepp Health Corporation ("Zepp Health" or the "Company") (NYSE:ZEPP), a global leader in smart wearables and health technology, today announced that it has filed its annual report on Form 20-F for the full year ended December 31, 2024 with the U.S. Securities and Exchange Commission (the "SEC"). The annual report can be accessed on the Company's investor relations website at http://ir.zepp.com and on the SEC's website at www.sec.gov. The Company will provide hardcopies of the annual report, free of charge, to its shareholders and ADS holders upon request. Requests should be submitted to [email protected]. About Zepp Health Corporation (NYSE:ZEPP) Z

      4/25/25 5:00:00 PM ET
      $ZEPP
      Computer Manufacturing
      Technology
    • Amazfit Announces the Bip 6 Smartwatch: The Everyday Smartwatch for Every Moment

      Featuring a Lightweight Design, Advanced Health Tracking, and Two-Week Battery Life Amazfit, a leading global smart wearable brand owned by Zepp Health (NYSE:ZEPP), a health technology company, today announced the launch of the Amazfit Bip 6 smartwatch. Featuring a vibrant 1.97-inch AMOLED display, advanced health and heart rate monitoring, AI-powered fitness programs, offline navigation, and comprehensive sleep tracking, the Bip 6 is designed to support everyday fitness enthusiasts at each stage of their health journey. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250331697403/en/Amazfit introduces Bip 6 Built for everyday du

      3/31/25 9:00:00 AM ET
      $ZEPP
      Computer Manufacturing
      Technology

    $ZEPP
    SEC Filings

    See more
    • Amendment: SEC Form SCHEDULE 13G/A filed by Zepp Health Corporation

      SCHEDULE 13G/A - Zepp Health Corp (0001720446) (Subject)

      5/7/25 11:05:28 AM ET
      $ZEPP
      Computer Manufacturing
      Technology
    • SEC Form 20-F filed by Zepp Health Corporation

      20-F - Zepp Health Corp (0001720446) (Filer)

      4/25/25 8:14:27 AM ET
      $ZEPP
      Computer Manufacturing
      Technology
    • SEC Form 6-K filed by Zepp Health Corporation

      6-K - Zepp Health Corp (0001720446) (Filer)

      3/27/25 6:07:53 AM ET
      $ZEPP
      Computer Manufacturing
      Technology

    $ZEPP
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13G/A filed by Zepp Health Corporation

      SC 13G/A - Zepp Health Corp (0001720446) (Subject)

      11/12/24 6:19:43 AM ET
      $ZEPP
      Computer Manufacturing
      Technology
    • Amendment: SEC Form SC 13G/A filed by Zepp Health Corporation

      SC 13G/A - Zepp Health Corp (0001720446) (Subject)

      10/4/24 8:26:45 AM ET
      $ZEPP
      Computer Manufacturing
      Technology
    • Amendment: SEC Form SC 13G/A filed by Zepp Health Corporation

      SC 13G/A - Zepp Health Corp (0001720446) (Subject)

      10/4/24 8:24:55 AM ET
      $ZEPP
      Computer Manufacturing
      Technology

    $ZEPP
    Leadership Updates

    Live Leadership Updates

    See more
    • Italian Tennis Star Jasmine Paolini Joins Amazfit as Latest Athlete Ambassador

      Paolini to Wear Amazfit Smart Wearables to Enhance Performance and Recovery. Amazfit logo to appear on Paolini's on-court apparel. Amazfit, a leading global smart wearables brand owned by Zepp Health (NYSE:ZEPP), today announced the signing of Italian tennis sensation and World No. 4 Jasmine Paolini as its newest global athlete partner. As part of the multi-year agreement and official smart wearable partnership, Paolini will represent Amazfit by wearing the Amazfit logo and smartwatch on court and the brand's fitness wearables, including Helio Ring, to track sleep and athletic recovery. This press release features multimedia. View the full release here: https://www.businesswire.com/news/h

      2/18/25 10:00:00 AM ET
      $ZEPP
      Computer Manufacturing
      Technology
    • Five-Time Olympic Medalist Gabby Thomas Joins Amazfit as Athlete Ambassador

      Amazfit becomes Thomas' first Smartwatch Partner Amazfit, a leading global smart wearables brand owned by Zepp Health (NYSE:ZEPP), is proud to announce five-time Olympic Medalist and fashion icon, Gabby Thomas, as the latest ambassador to join the brand's growing roster of elite athletes. As part of the four-year partnership, Thomas will wear Amazfit smartwatches both on the track during training and in competition, and off the track to monitor sleep and recovery. Moreover, through the Zepp app-based food log, Gabby will have easy access to nutrition-tracking as well. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250213824479

      2/13/25 12:00:00 PM ET
      $ZEPP
      Computer Manufacturing
      Technology